Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)

China flag China · Delayed Price · Currency is CNY
8.40
-0.42 (-4.76%)
Jul 21, 2026, 1:00 PM CST
Market Cap3.51B -14.0%
Revenue (ttm)1.38B -16.4%
Net Income14.25M
EPS0.04
Shares Out 398.52M
PE Ratio238.87
Forward PEn/a
Dividend0.18 (2.04%)
Ex-Dividend DateJun 8, 2026
Volume10,071,700
Open9.46
Previous Close8.82
Day's Range8.13 - 9.46
52-Week Range7.86 - 14.55
Beta0.53
Analystsn/a
Price Targetn/a
Earnings DateAug 22, 2026

About SHE:301060

Shanghai Labway Clinical Laboratory Co., Ltd. engages in the sale of in-vitro diagnostic products in China. The company distributes in-vitro diagnostic instruments, reagents, and related accessories and consumables. It also provides third-party medical testing, pathological diagnosis services, in-vitro diagnostic products, precision medicine, research and technical services, medical data management solutions and professional technical support services. In addition, the company offers leasing, business, and human resources services. The company ... [Read more]

Sector Healthcare
Founded 1993
Employees 1,245
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301060
Full Company Profile

Financial Performance

In 2025, SHE:301060's revenue was 1.45 billion, a decrease of -16.88% compared to the previous year's 1.74 billion. Losses were -30.75 million, -71.90% less than in 2024.

Financial Statements